Reduced-energy cranberry juice increases folic acid and adiponectin and reduces homocysteine and oxidative stress in patients with the metabolic syndrome

British Journal of Nutrition

Volumn 110, Issue 10, 2013, Pages 1885-1894

  Simão, Tathiana Name Colado ^a   Lozovoy, Marcell Alysson Batisti ^b   Simão, Andréa Name Colado ^c   Oliveira, Sayonara Rangel ^c   Venturini, Danielle ^c   Morimoto, Helena Kaminami ^c   Miglioranza, Lúcia Helena Silva ^c   Dichi, Isaias ^c  

^a Philadelphia University Center (UNIFIL) Londrina   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

^c UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Adiponectin; Cranberry juice; Folic acid; Homocysteine; Metabolic syndrome

Indexed keywords

ADIPONECTIN; ADVANCED OXIDATION PROTEIN PRODUCT; C REACTIVE PROTEIN; FOLIC ACID; HOMOCYSTEINE; HYDROPEROXIDE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANBERRY JUICE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS;

ADIPONECTIN; ADULT; ANTIOXIDANTS; BEVERAGES; CARDIOVASCULAR DISEASES; ENERGY INTAKE; FEMALE; FOLIC ACID; FRUIT; HOMOCYSTEINE; HUMANS; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; PLANT PREPARATIONS; PROTEIN CARBONYLATION; VACCINIUM MACROCARPON;

EID: 84887217234     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001207     Document Type: Article

References (83)

1. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607. (Pubitemid 19004941)
2. Ford ES, Giles WH & Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444-2449. (Pubitemid 39281399)
3. GrundySM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28, 629-636.
4. Festa A, D'Agostino R, Howard G, et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102, 42-47. (Pubitemid 30430551)
5. Santos AC, Lopes C, Guimarães JT, et al. (2005) Central obesity as a major determinant of increased high sensitivity C-reactive protein in metabolic syndrome. Int J Obes 29, 1452-1456. (Pubitemid 41622224)
6. Mckay DL & Blumberg JB (2007) Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutr Rev 65, 490-502. (Pubitemid 351804340)
7. Wang Y, Catana F, Yang Y, et al. (2002) An LCMS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem 50, 431-435. (Pubitemid 34106659)
8. Ruel G & Couillard C (2007) Evidences of the cardioprotective potential of fruits: the case of cranberries. Mol Nutr Food Res 51, 692-701. (Pubitemid 47083680)
9. Pedersen CB, Kyle J, Jenkinson AM, et al. (2000) Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr 54, 405-408. (Pubitemid 30261391)
10. Ruel G, Pomerleau S, Couture P, et al. (2005) Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 54, 856-861. (Pubitemid 40827199)
11. Ruel G, Pomerleau S, Couture P, et al. (2008) Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr 99, 352-359.
12. Lee IT, Chan YC, Lin CW, et al. (2008) Effect of cranberry extracts on lipid profiles in subjects with type 2 diabetes. Diabet Med 25, 1473-1477.
13. Basu A, Bettsa NM, Ortiz JA, et al. (2011) Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res 31, 190-196.
14. Fruchart JC, Nierman MC, Stroes ES, et al. (2004) New risk factors for atherosclerosis and patient risk assessment. Circulation 109, III-15-III-19. (Pubitemid 38786438)
15. Ziemke F & Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91, Suppl., 258S-261S.
16. Salehpour S, Broujeni PT & Samani EN (2009) Leptin, ghrelin, homocysteine and insulin resistance related to polycystic ovary syndrome. Int J Fertil Steril 2, 101-104.
17. Song Z, Zhou Z, Deaciuc I, et al. (2008) Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 47, 867-879. (Pubitemid 351449678)
18. Jacobs DR Jr (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and high blood cholesterol in adults (Adults Treatment Panel III). JAMA 285, 2486-2497.
19. U.S. Pharmacopeia (2007) USP Folic Acid Reference Standards, pp. 3276-3277. Rockville, MD: U.S. Pharmacopeia.
20. Lozovoy MAB, Simão ANC, Panis C, et al. (2011) Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus 20, 1250-1259.
21. Flecha BG, Llesuy S & Boveris A (1991) Hydroperoxideinitiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10, 93-100. (Pubitemid 121003216)
22. Witko-Sarsat V, Friedlander M, Khoa TN, et al. (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161, 2524-2532. (Pubitemid 28397070)
23. Selhub J (2006) The many facets of hyperhomocyste? ́nemia: studies from the Framingham cohorts. J Nutr 136, 1726S-1730S. (Pubitemid 43765388)
24. The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA 288, 2015-2022.
25. Wald DS, Law M, Morris JK, et al. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202-1208.
26. Kawashima A, Madarame T, Koike H, et al. (2007) Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia Pac J Clin Nutr 16, 411-421. (Pubitemid 47463617)
27. Paterson E, Gordon MH, Niwat C, et al. (2006) Supplementation with fruit and vegetables soups and beverages increases plasma carotenoid concentrations but does not alter markers of oxidative stress or cardiovascular risk factors. J Nutr 136, 2849-2855. (Pubitemid 44771785)
28. Panunzio MF, Pisano A, Antoniciello A, et al. (2003) Supplementation with fruit and vegetable concentrate decreases plasma homocysteine levels in a dietary controlled trial. Nutr Res 23, 1221-1228. (Pubitemid 37108385)
29. Samman S, Sivarajah G, Man JC, et al. (2003) A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 133, 2188-2193. (Pubitemid 36841538)
30. Setola E, Monti LD, Galluccio E, et al. (2004) Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151, 483-489. (Pubitemid 39430267)
31. Beattie J, Crozier A, Garry G, et al. (2005) Potential health benefits of berries. Curr Nutr Food Sci 1, 71-86.
32. Moat SJ, Doshi SN, Lang D, et al. (2004) Treatment of coronary heart disease with folic acid: is there a future? Am J Physiol Heart Circ Physiol 287, H1-H7. (Pubitemid 38802329)
33. Toole JF, Malinow MR, Chambless LE, et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction or death. The vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291, 565-575. (Pubitemid 38500310)
34. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. NEJM 354, 1567-1577.
35. Bonaa KH, Njolstad I, Ueland PM, et al. (2006) Homocysteine lowering and cardiovascular events after myocardial infarction. N Engl J Med 354, 1578-1588.
36. Albert CM, Cook NR, Gaziano JM, et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA 299, 2027-2036. (Pubitemid 351656584)
37. Ebbing M, Bleie O, Ueland PM, et al. (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography. JAMA 300, 795-804.
38. Yang Q, Botto LD, Erickson D, et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 1335-1343. (Pubitemid 43739455)
39. Casas JP, Bautista LE, Smeeth L, et al. (2005) Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365, 224-232. (Pubitemid 40138016)
40. Cronin S, Furie KL & Kelly PJ (2005) Dose-related association of MTHFR 677T allele with risk of ischemic stoke: evidence from a cumulative meta-analyses. Stroke 36, 1581-1587. (Pubitemid 40967536)
41. Spence JD, Bang H, Chambless LE, et al. (2005) Vitamin intervention for stroke prevention trial and efficacy analysis. Stroke 36, 2404-2409. (Pubitemid 41566967)
42. Lichtenstein AH & Russell RM (2005) Essential nutrients: food or supplements? Where should the emphasis be? JAMA 294, 351-358.
43. Wellen KE & Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119. (Pubitemid 40629025)
44. Kallio M, Kolehmainen DE, Laaksonen A, et al. (2007) Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr 85, 1417-1427.
45. Yudkin JS, Kumari M, Humphries SE, et al. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148, 209-214. (Pubitemid 30064452)
46. Tamakoshi K, Yatsuya H, Kondo T, et al. (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27, 443-449. (Pubitemid 36520842)
47. Yokota TK, Oritani I, Takahashi A, et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723-1732.
48. Ouchi N, Kihara S, Arita Y, et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476. (Pubitemid 30005109)
49. Ouchi N, Kihara S, Arita Y, et al. (2000) Adiponectin, an adipocyte derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 11, 1296-1130.
50. Hotta K, Funahashi T, Bodkin NL, et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126-1133. (Pubitemid 32374544)
51. Kern PA, Ranganathan S, Li C, et al. (2001) Adipose tissue tumor necrosis factor and IL-6 expression in human obesity and insulin resistance. Am J Physiol 280, E745-E751.
52. Maeda N, Takahashi M, Funahashi T, et al. (2001) PPARg ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 53, 2094-2099. (Pubitemid 33643677)
53. Arita Y, Kihara S, Ouchi N, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophy Res Commun 257, 79-83. (Pubitemid 29299050)
54. Hotta K, Funahashi T, Arita Y, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599. (Pubitemid 30353893)
55. Iwashima Y, Katsuya T, Ishikawa K, et al. (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43, 1318-1323. (Pubitemid 38691756)
56. Simão ANC, Lozovoy MAB, Simão TNC, et al. (2012) Adiponectinemia is associated with uricemia but not with proinflammatory status in women with metabolic syndrome. J Nutr Metab, 1-7.
57. Martinez-Flores S, Gutierrez-Fernadez B, Sanchez-Campos S, et al. (2005) Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1betaactivated rat hepatocytes. J Nutr 135, 1359-1365. (Pubitemid 40799596)
58. Youdim KA, McDonald J, Kalt W, et al. (2002) Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem 13, 282-288. (Pubitemid 34556689)
59. Nijveldt RJ, Van Nood E, Van Hoorn DEC, et al. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74, 418-425. (Pubitemid 32880250)
60. Fried SK, Bunkin DA & Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847-850. (Pubitemid 28496456)
61. Dichi I & Simão ANC (2012) Metabolic syndrome: new targets for an old problem. Expert Opin Ther Targets 16, 147-150.
62. McAnulty LS, Nieman DC, Dumke CL, et al. (2011) Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2•5 h of running. Appl Physiol Nutr Metab 36, 976-984.
63. Bere E (2007) Wild berries: a good source of omega-3. Eur J Clin Nutr 61, 431-433. (Pubitemid 46358785)
64. Itoh M, Suganami T, Satoh N, et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918-1925. (Pubitemid 47315642)
65. Lara JJ, Economou M, Wallace AM, et al. (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 193, 213-221. (Pubitemid 46776702)
66. Nagasawa A, Fukui K, Funahashi T, et al. (2002) Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34, 635-639. (Pubitemid 36398698)
67. Charles C, Yuskavage J, Carlson O, et al. (2009) Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 16, 395-400.
68. Simão ANC, Lozovoy MA, Bahls LD, et al. (2012) Blood pressure decrease with ingestion of a soy product (kinako) or fish oil in women with metabolic syndrome: role of adiponectin and nitric oxide. BJN 108, 1435-1442.
69. Sieminska L, Marek B, Kos-Kudia B, et al. (2004) Serum adiponectin in women with polycystic ovary syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest 27, 528-534. (Pubitemid 39255502)
70. Côte J, Caillet S, Doyon G, et al. (2010) Bioactive compounds in cranberries and their biological properties. Crit Care Food Sci Nutr 50, 666-679.
71. Heinonen M (2007) Antioxidant activity and antimicrobial effect of berry phenolics-a Finnish perspective. Mol Nutr Food Res 51, 684-691. (Pubitemid 47083679)
72. Kahkonen MP, Hopia AI, Vuorela HJ, et al. (1999) Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 47, 3954-3962. (Pubitemid 29506183)
73. Williamson G & Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 93 intervention studies. Am J Clin Nutr 81, 243S-255S.
74. Badawy A, State O, Gawad SSH, et al. (2006) Plasma homocysteine and PCOS: the missed link. Eur J Obstet Gynecol Rep Biol 5, 112-116.
75. Ekmekçi H, Ekmekçi B, Erdine S, et al. (2008) Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension. J Thromb Thrombolysis 28, 418-424.
76. Maahs DM, Ogden LG, Kinney GL, et al. (2005) Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111, 747-753. (Pubitemid 40250635)
77. Hayden MR & Tyagi SC (2004) Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J 3, 4-15.
78. Dominguez LJ, Galioto A, Pineo A, et al. (2010) Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus. J Am Coll Nutr 29, 1-6.
79. Tyagi N, Sedoris KC, Steed M, et al. (2005) Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289, H2649-H2656. (Pubitemid 41699830)
80. Freedman JE, Parker C 3rd, Li L, et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103, 2792-2798. (Pubitemid 32550066)
81. Keevil JG, Osman HE, Reed JD, et al. (2000) Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 130, 53-56. (Pubitemid 30032829)
82. O'Byrne DJ, Devaraj S, Grundy SM, et al. (2002) Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76, 1367-1374. (Pubitemid 35416574)
83. Zhu W, Cheng KKY, Vanhoutte PM, et al. (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci 114, 361-374. (Pubitemid 351397385)